ライフサイエンスコーパス: direct-to-consumer

1 If other direct-to-consumer ads were to communicate outcome data

2 Direct-to-consumer advertisement (DTCA) and physician pr

3 reasingly available to the public via online direct-to-consumer advertisement within the United State

4 maceutical companies spent US$1.8 billion on direct-to-consumer advertisements for prescription drugs

5 zed clinical trials to examine the impact of direct-to-consumer advertisements on the efficacy of a b

6 Although cancer-related direct-to-consumer advertising (CR-DTCA) is prevalent, l

7 Direct-to-consumer advertising (DTCA) also increased dur

8 tes is one of only two countries that permit direct-to-consumer advertising (DTCA) of prescription dr

9 Content analysis of cancer-related direct-to-consumer advertising (DTCA), with a focus on h

10 Finally, we documented the variation in direct-to-consumer advertising among and within five the

11 s in spending by pharmaceutical companies on direct-to-consumer advertising and promotion to physicia

12 Consumers see $4 billion of direct-to-consumer advertising annually, which typically

13 s of this cross-sectional study suggest that direct-to-consumer advertising campaigns for teprotumuma

14 Given that direct-to-consumer advertising campaigns have the potent

15 Annual spending on direct-to-consumer advertising for prescription drugs tr

16 n of total promotional spending allocated to direct-to-consumer advertising for the remaining 134 dru

17 Spending on direct-to-consumer advertising has continued to increase

18 Although the use of direct-to-consumer advertising has grown disproportionat

19 urinary incontinence have had mixed results; direct-to-consumer advertising has increased public awar

20 Although during that time spending on direct-to-consumer advertising increased by 330%, it mad

21 Evidence suggests that direct-to-consumer advertising of prescription drugs inc

22 is public concern about the possibility that direct-to-consumer advertising of prescription drugs wil

23 rapid proliferation of businesses engaged in direct-to-consumer advertising of unproven stem cell int

24 The initial surge in direct-to-consumer advertising preceded the 1997 FDA gui

25 portion of promotional spending allocated to direct-to-consumer advertising was 13.5% (IQR, 1.96%-36.

26 market areas, regional exposure to televised direct-to-consumer advertising was associated with great

27 y suggest that the amount hospitals spent on direct-to-consumer advertising was not associated with p

28 here is marked variation in the intensity of direct-to-consumer advertising, and the amount of such a

29 ines that clarified the rules for electronic direct-to-consumer advertising, and thus the 1997 guidel

30 rs, including convenience of administration, direct-to-consumer advertising, or insurance restriction

31 Some drugs are heavily marketed through direct-to-consumer advertising.

32 to be responsible for unleashing a flood of direct-to-consumer advertising.

33 urer total promotional spending allocated to direct-to-consumer advertising.

34 n of total promotional spending allocated to direct-to-consumer-advertising for each drug.

35 cal DNA and large datasets generated through direct-to-consumer ancestry testing.

36 d OOP costs were separately compared between direct-to-consumer and generic-only commercial prices.

37 lity to calculate polygenic risk scores from direct-to-consumer and health-care-associated biobanks h

38 The difference between direct-to-consumer and overall commercial insurance plan

39 Direct-to-consumer campaigns generally begin within a ye

40 In 2019 U.S.-based direct-to-consumer companies marketing NFACT persisted d

41 iduals have access to raw genomic data using direct-to-consumer companies.

42 dary Findings in the Clinical, Research, and Direct-to-Consumer Contexts ) recommends that a research

43 Direct-to-consumer (D2C) wearables are becoming increasi

44 on (tCS) is reflected by the recent surge in direct-to-consumer device marketing, do-it-yourself enth

45 ectronic industries and have begun to market direct-to-consumer DNA testing.

46 Millions of people have taken direct-to-consumer DNA tests, but not everyone is happy

47 Although direct-to-consumer (DTC) advertisements for pharmaceutic

48 Direct-to-consumer (DTC) advertisements for prescription

49 The most rapid increase was in direct-to-consumer (DTC) advertising, which increased fr

50 The recent provision of direct-to-consumer (DTC) Anti-Mullerian Hormone (AMH) te

51 databases and pave the way for clinical and direct-to-consumer (DTC) applications.

52 In the direct-to-consumer (DTC) context, where raw data are oft

53 Increasing public interest in direct-to-consumer (DTC) genetic ancestry testing has be

54 ed for clinical use but is available through direct-to-consumer (DTC) genetic testing companies.

55 Direct-to-consumer (DTC) genetic testing for disease sus

56 Direct-to-consumer (DTC) genetic testing has attracted a

57 ars, the number of patients choosing to have direct-to-consumer (DTC) genetic testing without involvi

58 genealogy has become popular as a result of direct-to-consumer (DTC) genetic testing.

59 Direct-to-consumer (DTC) genetics services are increasin

60 there have been notable developments in the direct-to-consumer (DTC) genomic testing arena, in parti

61 d use, consumer attitudes and opinions about direct-to-consumer (DTC) models of health care are often

62 Direct-to-consumer (DTC) personal genomic testing (PGT)

63 DNA sequencing, which has led to the rise of direct-to-consumer (DTC) sequencing, e.g. 23andme.com, a

64 ug discovery efforts to big-data methods and direct-to-consumer (DTC) strategies.

65 Prior research found that pediatric direct-to-consumer (DTC) telemedicine visits are associa

66 known about the quality of rapidly expanding direct-to-consumer (DTC) telemedicine websites and smart

67 ncerns about exposure to malpractice risk in direct-to-consumer (DTC) telemedicine, this study review

68 Personal genome tests are now offered direct-to-consumer (DTC) via genetic variants identified

69 Direct-to-consumer education reduces chronic sedative us

70 randomized to the intervention (a codesigned direct-to-consumer educational brochure sent by mail) or

71 o expanding use of diagnostic, research, and direct-to-consumer exome and genome sequencing.

72 other lawmakers must act to robustly protect direct-to-consumer genetic data and biospecimens into th

73 If direct-to-consumer genetic test information is used in c

74 Only 3.4% of survivors had direct-to-consumer genetic testing (DTCt) for cancer.

75 In many cases, direct-to-consumer genetic testing advertises informatio

76 -effectiveness evaluation of glaucoma PRS in direct-to-consumer genetic testing and across different

77 With the proliferation of direct-to-consumer genetic testing and the advent of per

78 cle, we discuss the rapidly evolving area of direct-to-consumer genetic testing and the current utili

79 Direct-to-consumer genetic testing companies, such as 23

80 erningly, the debriefing currently used by a direct-to-consumer genetic testing company failed to cou

81 Despite insufficient evidence to support direct-to-consumer genetic testing in routine clinical c

82 fic statement, we summarize the state of the direct-to-consumer genetic testing industry, review type

83 Navigating clinical questions about direct-to-consumer genetic testing involves understandin

84 st in human genetics and precision medicine, direct-to-consumer genetic testing is becoming increasin

85 d oversight of the marketplace; the scope of direct-to-consumer genetic testing offerings; and the ri

86 Here, we use data derived from direct-to-consumer genetic testing to investigate patter

87 genetic information that may be included in direct-to-consumer genetic testing, describe approaches

88 es for clinicians navigating questions about direct-to-consumer genetic testing.

89 How the FDA should regulate direct-to-consumer genetic tests is fiercely contested.

90 rivacy challenges in the context of emerging direct-to-consumer genetic-testing applications.

91 s bankruptcy was an inflection point for the direct-to-consumer genetics market.

92 The use of direct-to-consumer genomewide profiling to assess diseas

93 sharing and their potential applications in direct-to-consumer genomic testing and forensic analyses

94 l genetics of 40 phenotypes generated from a direct-to-consumer genotype cohort.

95 has been returned to millions of persons by direct-to-consumer genotyping companies.

96 ors, including health care, research and the direct-to-consumer industry, have led to a dramatic incr

97 Direct-to-consumer marketing and shared decision making

98 sed by commercial weight loss centers or for direct-to-consumer marketing by manufacturers and does n

99 rtant questions about the appropriateness of direct-to-consumer marketing for oncologic medications.

100 nd the high costs associated with screening, direct-to-consumer marketing of helical CT is not advisa

101 Direct-to-consumer marketing of unapproved stem cell int

102 r ocular conditions is readily available via direct-to-consumer marketing strategies across the Unite

103 Encouraged by direct-to-consumer marketing, smokers and their physicia

104 n a substantial surge in the availability of direct-to-consumer mobile applications (apps) claiming t

105 Moreover, the availability of direct-to-consumer NGS services is fuelling a rise of 'c

106 ompanies that are U.S. based, participate in direct-to-consumer online marketing, have websites that

107 offering tests using genome-wide technology direct to consumers over the internet.

108 ruse of health care resources in response to direct-to-consumer personal genomic testing (PGT).

109 Conclusion Most adults receiving elevated direct-to-consumer PGT single nucleotide polymorphism-ba

110 Cs in television commercials-physicians used direct-to-consumer pharmaceutical advertising about DOAC

111 titioners should be aware of options such as direct-to-consumer pharmacies because they can often del

112 tient assistance programs, pharmacy coupons, direct-to-consumer pharmacies, public assistance program

113 ase drugs directly using pharmacy coupons or direct-to-consumer pharmacies, which sometimes offer low

114 If pharmacies with direct-to-consumer pharmacy cost structures were widely

115 In generic-only costs, no direct-to-consumer pharmacy medications had lower OOP an

116 In total costs, 55% of the direct-to-consumer pharmacy medications had lower total

117 The direct-to-consumer pharmacy OOP costs were 75% higher an

118 ons (42%) available for purchase through the direct-to-consumer pharmacy were studied.

119 al study compared medication costs through a direct-to-consumer pharmacy with model-estimated 2024 co

120 ll commercial prescriptions were filled in a direct-to-consumer pharmacy, the aggregate OOP expenditu

121 (-18%) had lower OOP and total costs in the direct-to-consumer pharmacy, with no other medications h

122 had the largest percentage reduction in the direct-to-consumer pharmacy.

123 er medications having lower OOP costs in the direct-to-consumer pharmacy.

124 t, we share our first-hand experience with 2 direct-to-consumer platforms, where we intentionally sou

125 Direct-to-consumer prescription drug ads typically fail

126 The direct-to-consumer pricing for each medication was obtai

127 nal clinical trials has been supplemented by direct to consumer products with advancement of wearable

128 biobanks, randomized controlled trials, and direct-to-consumer profiling in tens of millions of peop

129 Direct-to-consumer promotion of lung cancer screening ha

130 ingly commonplace in research, clinical, and direct-to-consumer settings.

131 wth of telehealth services has brought about direct-to-consumer telemedicine platforms, enabling pati

132 when comparing 30 216 patients with definite direct-to-consumer telemedicine visits with 30 216 patie

133 ared with visits with a physician working in direct-to-consumer telemedicine.

134 Direct-to-consumer testing challenges many of the assump

135 One of the significant challenges of direct-to-consumer testing is that it shifts the control

136 e to clinicians and even to patients through direct-to-consumer testing, uptake of genetic testing re

137 lts, which their parents had received from a direct-to-consumer vendor.